baber/WOPTO huggingface dataset:
Patent NZ-281277-A (NZ)
Title: Telephone call pricing; method and system in which a set of factors allowing selection of a specific call tariff is extracted from a call record and two data bases
Inventor: GORDON DALE ROBERT
IPC: H04M/
Filed: 1995-02-28
Abstract: PCT No. PCT/GB95/00422 Sec. 371 Date Jan. 29, 1996 Sec. 102(e) Date Jan. 29, 1996 PCT Filed Feb. 28, 1995 PCT Pub. No. WO95/24093 PCT Pub. Date Sep. 8, 1995A telephone charging system prices calls made by customers in a telecommunications network. The system includes a local exchange which provides a call record for each call, a database containing details of the customers of the network, a database which contains the locations of the individual numbers, details of routes between the numbers and a set of tariffs for pricing calls, a processor which receives call records from the local exchange and data from the databases and uses the call records and data to price calls, and a store for storing details of the priced calls. In order to price a typical call, the processor evaluates a factor relating to the type of service used in the call, a factor relating to the type of customer, a factor relating to the locations of the calling and called number in the network and a factor relating to the day on which the call is made. The values of the factors are used to select the tariff from the set of call tariff stored in database and the call is then priced in accordance with this tariff.
Patent NZ-288429-A (NZ)
Title: Self-sustaining pyrolytic conversion of waste material into beneficial products
Inventor: MCMULLEN FREDERICK G
IPC: C01B31/08
Filed: 1995-06-01
Abstract: A self-sustaining system and process for converting organic waste feedstreams into usable solid and gas end products includes a plurality of interconnected retorts, an apparatus for flash pyrolyzing the feedstream to form intermediate gas and solid products, a means for introducing a water spray to refine and cool the intermediate products, a means for separating the gas product from the solid product and a means for regenerating, and thereby further refining, the solid product. In a self-sustaining process, wastes which would otherwise be landfilled are converted to an activated carbon product and a combustible gas mixture of hydrogen, carbon monoxide, and lower hydrocarbons.
Patent NZ-288988-A (NZ)
Title: Hydromorphone delivery system
Inventor: GROSSMAN STUART A
IPC: A61K9/00
Filed: 1995-06-20
Abstract: A non-abusable, non-inflammatory, biocompatible, non-biodegradable, subcutaneous, polymeric implant for the prolonged, controlled release of hydromorphone with near zero-order kinetics is described. Methods of alleviating cancer pain and treating opioid drug addiction with the implant are also described.
Patent NZ-301429-A (NZ)
Title: Gel composition containing a carbonaceous compound
Inventor: BOES RALPH ULRICH
IPC: B01J13/00
Filed: 1995-12-14
Abstract: The present invention relates to a gel composition comprising a carbonaceous component selected from carbon fibres, activated carbons, and graphitic attached to a gel component selected from the group metal oxide gels, resorcinol-formaldehyde gels, melamine formaldehyde gels and phenol-furfural gels. Also claimed is a thermal comprising the gel composition above.
Patent NZ-311181-A (NZ)
Title: Obtaining metabolic mutants involving random mutations and specific selection not having recombinant DNA and a nucleic acid cassette encoding a bidirectional marker, and inducible enhancer and a basic transcription unit
Inventor: DE GRAAF LEENDERT HENDRIK
IPC: C12N15/63
Filed: 1996-06-24
Abstract: A nucleic acid cassette comprising a nucleic acid sequence encoding a bidirectional marker is claimed. The nucleic acid cassette further comprises a basic transcriptional unit operatively linked to the nucleic acid sequence encoding the bidirectional marker. The nucleic acid cassette further comprises an inducible enhancer or activator sequence linked to the basic transcription unit in such a manner that upon induction of the enhancer or activator sequence the bidirectional marker encoding nucleic acid sequence is expressed. The inducible enhancer or activator sequence is derived from a gene associated with activity of part of metabolism, said inducible enhancer or activator sequence being derived from a gene associated with metabolism.
Patent NZ-330098-A (NZ)
Title: A rack and pinion door drive device for an automatic door with rack having bifurcate transverse section to locate onto rail of door track
Inventor: COUBRAY BRUCE ARTHUR
IPC: F16H55/26
Filed: 1998-03-31
Abstract: The door (typically having sections 103) is constrained by attached rack 104 and wheels 102 which move in track 101.  Rack 104 is bifurcated and is partly inside and partly outside of a wall of track 101.
Patent NZ-333918-A (NZ)
Title: Self-adhesive label includes a multilaminar portion disposed on a first portion of a self-adhesive base
Inventor: BARRY DAVID ROBERT
IPC: G09F3/00
Filed: 1997-08-05
Abstract: A self-adhesive label comprising a self-adhesive base carried on a backing of release material, a multi-laminar portion disposed on a first portion of the base, a layer of adhesive on a second portion of the base adjacent to the first portion, and a printed cover sheet having a first edge portion which is adhered to the base by the layer of adhesive, a central portion which extends over the multi-laminar portion, and a second edge portion opposite to the first edge portion which is arranged to be held against the backing of release material thereby to retain the self-adhesive label in a closed configuration.
Patent NZ-336889-A (NZ)
Title: Apparatus for intubation of the lacrimal duct comprising a thicker and a thinner tube and a stopper attached to one end of the thinner tube
Inventor: KURIHASHI KATSUAKI
IPC: A61F9/007
Filed: 1999-07-26
Abstract: This apparatus is for the treatment of the lacrimal duct; and is characterized in that both ends of a thinner and softer tube or rod 0.5-0.7 mm OD and 20-40 mm in length are connected with thicker and harder tubes (0.9-1.2 mm OD and 15-50 mm in length), resulting in a total length of 50-120 mm.  Both ends (2 mm) are sealed by silicone to make the closed end and then formed sharp pointed in conical shape.
Patent NZ-500380-A (NZ)
Title: Side terminal for direct vent fireplace with curved cover to dissipate exhaust gases
Inventor: RADKE GEORGE F
IPC: F23L17/04
Filed: 1999-10-14
Abstract: Exhaust gases flow in direction 123 and impact against curved inner surface 110 of outer cover 104 (being arcuate and generated about at least one vertical axis).  This is stated to smoothly dissipate exhaust gases and reduce back pressure within exhaust duct 111, and to provide minimal overhand of the terminal from the building wall.
Patent NZ-504622-A (NZ)
Title: Reflective compositions for combatting insects and viruses transmitted to plants thereby
Inventor: SANDER RONEN
IPC: A01N59/00
Filed: 1998-12-09
Abstract: A method for protecting growing plants from insects and from insect-transmitted plant viruses, which comprises applying to a locus or loci selected from surfaces of growing plants and their background, a composition comprising reflective particles of at least one pearl luster pigment, whereby this composition is effective to repel those insects and thus protect the plants. A composition for protecting growing plants from insects and from insect-transmitted plant viruses, which comprises reflective particles of at least one pearl luster pigment, together with at least one agriculturally acceptable diluent, carrier or adjuvant.
Patent NZ-507264-A (NZ)
Title: Simulated fuel bed for fireplace having reflectors disposed in an ember pattern on at least one of the ember bed and combustible fuel
Inventor: HESS KRISTOFFER
IPC: F24C7/00
Filed: 1999-03-04
Abstract: A  simulated fuel bed for an electric or gas fireplace including an ember bed and a combustible fuel. At least  one reflector  is mounted to at least one of the ember  bed  and the  combustible fuel in a position to simulate a hot  ember by  reflecting  light transmitted from a light  source  (not shown).
Patent NZ-507296-A (NZ)
Title: Electronic budgeting and bill payments system
Inventor: BAYNE MARY
IPC: H04Q7/00
Filed: 2000-10-02
Abstract: A service provider budgeting and bills payment method and system thereof for use with a plurality of customers executed on a computer system comprises: (a) preliminarily agreeing to pay customer nominated bills from a plurality of billers over a defined period and/or make monetary advances to a customer; (b) entering data characterising the bills and/or the advances into the computer system; (c) using the computer system to derive an estimate of the total amount to be paid to a customer and a customer's billers over the period and to calculate a periodic payment to be made by a customer which in total for the period will equal the total amount plus service provider fees already loaded in the computer system; (d) establishing a customer payment mechanism for collecting the periodic payment from the customer and entering data identifying the payment mechanism together with the periodic payment amount into the computer system; (e) establishing a bill payment mechanism with each nominated biller and entering data identifying the bill payment mechanism into the computer system; (f) receiving bills from each biller and entering into the computer system the billed amount where these are not fixed and entered in advance; (g) the computer system causing payment to be made to each biller according to the established payment mechanism; (h) preliminarily agreeing to pay additional customer nominated bills or advances during the period and repeating steps (b) to (e) as appropriate; (i) the computer system being triggered by predetermined criteria to periodically analyse each customer's bills and advances and repeating steps (b) to (d) as appropriate.
Patent NZ-509295-A (NZ)
Title: Synergistic compositions comprising ascorbate and lysine for states related to extra cellular matrix degeneration
Inventor: RATH MATTHIAS
IPC: A61K31/715
Filed: 2001-01-10
Abstract: The use of ascorbate and a fibrinolysis-collagenasis inhibitor in a synergistic composition to treat collagenase-linked degenerative diseases.  The addition of the ascorbate integer helps to overcome the pro-coagulative effects of the fibrinolysis inhibitors.
Patent NZ-511364-A (NZ)
Title: A method and device for an EGR-system having a valve with dampers one of which is always maintained open
Inventor: BLOMQVIST MICAEL
IPC: F02M25/07
Filed: 1999-11-09
Abstract: A method for recirculating a part of exhaust gases from an exhaust pipe of a diesel engine to an inlet of the engine.  The exhaust gases are diverted from the exhaust pipe and directed through a recirculation conduit to a controllable valve device arranged between the engine and an air intake thereof to enable supply of air/recirculated exhaust gases in a desired relation to a combustion chamber of the engine.  The valve device comprises dampers arranged in inlet channels for the recirculated exhaust gases and air respectively.  At least one of the dampers is always open and the other damper is closed by means of a drive motor common to all the dampers.
Patent NZ-511609-A (NZ)
Title: Erythromycin derivatives useful as antibiotics
Inventor: AGOURIDAS CONSTANTIN
IPC: C07D233/54
Filed: 1999-11-09
Abstract: A compound or it salts thereof has the formula (I) wherein: X is hydrogen or halogen and Z is hydrogen or alkanoyl. The compound is useful for treating bacterial infections.
Patent NZ-514818-A (NZ)
Title: Compounds and methods for therapy and diagnosis of lung cancer
Inventor: WANG TONGTONG
IPC: C12N5/09
Filed: 2000-04-03
Abstract: An isolated polypeptide encoding a lung tumour protein, comprising a sequence as disclosed in the specification, an expression vector comprising said protein, a host cell transformed by said vector, and an isolated antibody, or antigen binding fragment thereof that specifically binds to said lung tumour protein are disclosed. Also covered is a pharmaceutical composition comprising one of above detailed components, a vaccine, the use of said pharmaceutical composition and vaccine in the manufacture of a medicament for the treatment of lung cancer, a method for removing tumour cells from a biological ample, comprising contacting said sample with T cells that specifically react with a lung tumour protein, wherein the protein is as described above, a method of stimulating T cells specific for said lung tumour protein, a method of determining the presence or absence of a lung tumour in a patient and a method for monitoring the progression of lung cancer in a patient.
Patent NZ-524588-A (NZ)
Title: Manipulation of flowering and plant architecture using MADS-box proteins (MADS), CENTRORADIALIS (CEN), APETALA2 (AP2) and Homeo-box proteins (HB) from ryegrass (Lolium) and fescue (Fesctuca) species
Inventor: SPANGENBERG GERMAN
IPC: A01H5/00
Filed: 2001-10-17
Abstract: A substantially purified or isolated nucleic acid encoding CENTRORADIALIS (CEN) and its polypeptide from a ryegrass (Lolium) species are described. Vectors and plant cells comprising the nucleic acid are described. The nucleic acid can be introduced into a plant to modify plant life cycles and/or growth phases, flowering processes, flowering and/or plant architecture and flower and/or inflorescence development in a plant, or can be used as a molecular marker.
Patent NZ-526594-A (NZ)
Title: Diphenyl azetidinone derivatives, method for the production thereof, medicaments containing these compounds, and their use
Inventor: GLOMBIK HEINER
IPC: A61P3/06
Filed: 2001-12-11
Abstract: Diphenyl azetidinone compounds of formula (I) and their physiologically compatible salts that are suitable for use e.g. as hypolipidemic drugs, a method for the production thereof, medicaments containing these compounds, and their use is disclosed, wherein R1, R2, R3, R4, R5 and R6 are as defined in the specification.
Patent NZ-532368-A (NZ)
Title: Carbonylbenzoxazine compounds for enhancing glutamatergic synaptic responses
Inventor: ROGERS GARY A
IPC: A61P25/24
Filed: 2002-11-25
Abstract: Disclosed are compounds of structure Ia or Ib, wherein: Q and Q' are independently H, -CH2-, -O-, -S-, alkyl or substituted alkyl, R1 is H, alkyl or together with Q may be a cycloalkyl ring, R2 may be absent or -CH2-, -CO-, -CH2CH2-, -CH2CO-, -CH2O-, -CRR'-, or -CONR-, Y is H or -OR3 or links A to A' as a single bond, =N- or -NR-, A is -NRR', -OR, alkyl, substituted alkyl, cycloalkyl, substituted cycloalkyl, cycloalkylalkyl, aryl, substituted aryl, heterocycle or substituted heterocycle, A' is -NRR', and X and X' are independently R, halo, -CO2R, -CN, -NRR', -NRCOR', -NO2, -N3 or -OR. The compounds are used for the manufacture of medicaments for the treatment of conditions wherein the subject suffers from a hypoglutamatergic condition or deficiencies in the number or strength of excitatory synapses or in the number of AMPA receptors such that a cortical/striatal imbalance occurs leading to schizophrenia or schizophreniform behaviour.
Patent NZ-533737-A (NZ)
Title: A nutrient pharmaceutical formulation comprising polyphenols and use in treatment of cancer
Inventor: NETKE SHRIRANG
IPC: A61K31/375
Filed: 2003-01-13
Abstract: A nutrient pharmaceutical composition that is useful in treating cancer and comprises: (a) an ascorbic compound; (b) a L-lysine compound; (c) a L-proline compound; and (d) at least one polyphenol compound selected from the group consisting of epigallocatechin gallate, epicatechin gallate, epigallocatechin, epitechin, and catechin, wherein the compounds (a)-(c) enhance the polyphenol compound's activity in blocking cancer proliferation and metastasis. Also described is the use of the nutrient composition and optionally N-acetyl cysteine for preparation of a pharmaceutical composition for the treatment of an inflammatory disease such as osteoarthritis.
Patent NZ-533783-A (NZ)
Title: Recombinational cloning using nucleic acids having recombinational sites
Inventor: HARTLEY JAMES L
Filed: 1998-10-26
Abstract: Disclosed are compositions comprising both a polypeptide and a nucleic acid coding for a recombination site. Preferably the polypeptide has nucleotide polymerase, DNA polymerase, or reverse transcriptase activity, and the recombination side is an att site.
Patent NZ-535230-A (NZ)
Title: Crystals of glucopyranosyloxybenzyl benzene derivative
Inventor: IYOBE AKIRA
IPC: A61P3/04
Filed: 2003-03-04
Abstract: Disclosed is a crystal of 2-(4-methoxybenzyl)phenyl 6-O-ethoxy-carbonyl-beta-D-glucopyranoside. Crystals of the type disclosed are useful in the manufacture of a medicament for preventing or treating a disease associated with hyperglycemia.
Patent NZ-541164-A (NZ)
Title: The extraction and treatment of heavy metals
Inventor: STARKS CHRISTOPHER MICHAEL
IPC: C02F1/66
Filed: 2004-01-19
Abstract: Disclosed is a method of decontaminating heavy metal contaminated soil or sludge in which contaminated waste streams or soil or sludge is subjected to a first treatment stage with an acid liquor at a pH below 2 and at a solids content from 5 to 30%; then the liquid and solid phases from the first treatment stage are separated; the solids from the first treatment stage are mixed with a fresh acid liquor at a pH below 2 and a solids content from 5 to 30%; the liquid and solid phases from the second treatment stage are separated; the liquor separated from the first treatment stage is reacted with a base to precipitate the metals; the precipitated metals are separated and the liquor is recycled for reuse in the process; the solids separated from the second treatment stage are neutralized to adjust the pH to a level acceptable for a soil conditioner or fertilizer or other customized products; and the liquor from the second stage is used as the acidic liquor in the first treatment stage. Where the sludge contains hydrogen sulphide the treatment stages are conducted in closed vessels containing a source of ozone in the head space to convert the hydrogen sulphide into a soluble sulphurous or sulphuric acid. The process has the advantage of avoiding any liquid effluent.
Patent NZ-542018-A (NZ)
Title: Immunopotentiating agent for use in animals
Inventor: SORGENTE NINO
IPC: A23K1/16
Filed: 2004-01-26
Abstract: A method for producing an immunopotentiating agent from cell walls of yeast, other fungi or bacteria is provided and its use as an additive to animal feed to increase resistance to various infections and to potentiate the effect of vaccines is described.
Patent NZ-548305-A (NZ)
Title: Empty container detection using container side pressure sensing
Inventor: VANDERVEEN TIMOTHY W
IPC: A61M5/142
Filed: 2004-12-28
Abstract: A system for determining when a fluid container connected to an infusion pump having a pumping mechanism by an infusion line has been emptied of fluid is disclosed. The system comprises a pressure sensor in operable communication with the fluid line and disposed at a location between the container and the pumping mechanism. The pressure sensor is capable of monitoring a pressure within the fluid line and providing signals representative of pressure related values of the monitored pressure. The system further comprises a memory adapted to store the pressure related values; and a processor in operable communication with the pressure sensor and the memory, the processor programmed to receive signals from the pressure sensor and sample the received signals at selected intervals. The processor is also programmed to calculate a first averaged sampled pressure value from signals received during a first selected interval and store the first averaged sampled pressure value in the memory. The processor is also programmed to compare the stored first averaged sampled pressure value with a second averaged sampled pressure value calculated from signals received during a second selected interval and provide a container empty signal if the comparison results in a difference between the first and second calculated averaged sampled pressure values reaches a predetermined threshold.
Patent NZ-548980-A (NZ)
Title: Reducing serum proinsulin levels in type 2 diabetics
Inventor: CHEATHAM WAYMAN WENDELL
IPC: A61K38/28
Filed: 2005-01-10
Abstract: Provided is the use of an insulin composition including a diketopiperazine in the manufacture of a prandial medicament suitable for administration to a mammalian subject with type 2 diabetes having an elevated proinsulin level, for reducing a risk factor of atherosclerosis in said subject, wherein the medicament is formulated for pulmonary administration, and wherein the medicament is formulated to produce a rapid and early onset of insulin action.
Patent NZ-549249-A (NZ)
Title: Methods for reducing the incidence of mastitis by administration of keratin
Inventor: WILLIAMSON NORMAN BRUCE
IPC: A61D1/02
Filed: 2006-08-18
Abstract: Disclosed are methods of reducing the incidence of mastitis, inducing leucycytosis and of sealing a teat canal of a non-human animal such as a cow, including the step of introducing a composition including keratin into the teat canal of the animal, thereby reducing the incidence of mastitis in said animal. Also disclosed is a teat seal including keratin formulated for introduction into the teat canal of a non-human animal, wherein the composition is a solid or semi-solid.
Patent NZ-550546-A (NZ)
Title: Elastic element produced from radiolucent material for a medical device
Inventor: OESCH MARC
IPC: A61L31/14
Filed: 2004-04-19
Abstract: The disclosure relates to an elastic element (1) which consists of a radiolucent material and is provided for a medical device. Said elastic element (1) is produced from an unreinforced plastic material.
Patent NZ-552414-A (NZ)
Title: Lighting apparatus in the visor of a hat
Inventor: DYER SIMON
Filed: 2006-12-22
Abstract: A visor portion capable of being attached to a head engaging portion is disclosed. The visor portion has a first upward facing surface (first surface) and a second downward facing surface (second surface). The visor portion contains at least one part ovoid shaped bubble projection on the second surface which houses at least one light emitting source. The visor portion can also contain at least one activation switch which is used to complete one or more of the following functions: (a) turn the light emitting source(s) on; (b) turn the light emitting source(s) off; (c) place the light emitting source(s) into an on or off sequence; (d) adjust the light emitting source(s) brightness.
Patent NZ-560410-A (NZ)
Title: Prion protein ligands and methods of use
Inventor: HAMMOND DAVID J
IPC: C07K5/093
Filed: 2003-12-03
Abstract: Disclosed is a prion binding ligand, wherein the ligand is a peptide having an amino acid sequence of SEQ ID NO:114. Also disclosed is a method for detecting a prion with said ligand and compositions thereof.
Patent NZ-571069-A (NZ)
Title: Cooling a brake disc by air flow though the wheel rim with the disc mounted the rim using it as a heatsink
Inventor: FENNA WILLIAM EDWARD
IPC: F16D65/78
Filed: 2006-02-07
Abstract: A braking system with cooling is disclosed. The system has an axle and a support element (2) with openings (10), such as a wheel rim, mounted on the axle. A brake ring (3) is connected to the periphery of the support element (2) and a brake calliper (7) situated to the inside of the brake ring (3). The brake ring (3) is connected to the support element (2) such that heat flows by conduction from the brake ring (3) into the support element (2) so that it acts as a heat sink to the brake ring (3). An air current generating means (11) caused a flow of air through the openings (10) in the support element (2) and over the brake ring (3) and brake calliper (6), cooling both.